Terapia Génica en Enfermedad de Parkinson
PARKBA SAL
Universidad de La Laguna
San Cristobal de La Laguna, EspañaPublicaciones en colaboración con investigadores/as de Universidad de La Laguna (7)
2014
-
Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons
Frontiers in Neuroanatomy, Vol. 8, Núm. AUG
2009
-
Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease
Neurobiology of Disease, Vol. 36, Núm. 3, pp. 494-508
2006
-
Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats
European Journal of Neuroscience, Vol. 23, Núm. 8, pp. 2099-2108
2005
-
Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells
European Journal of Neuroscience, Vol. 21, Núm. 7, pp. 1815-1827
2004
-
How does Parkinson's disease begin? The role of compensatory mechanisms (multiple letters)
Trends in Neurosciences
-
The origin of motor fluctuations in Parkinson's disease: Importance of dopaminergic innervation and basal ganglia circuits
Neurology, Vol. 62, Núm. 1 SUPPL. 1
2000
-
Pathophysiology of the basal ganglia in Parkinson's disease
Trends in Neurosciences, Vol. 23, Núm. 10 SUPPL.